Navigation Links
New Primer Co-Authored by Novation Describes Potential Impact of Biosimilars on Pharmacy Practice; Opportunity for Hospitals to Manage Drug Expenditures
Date:11/20/2013

IRVING, Texas, Nov. 20, 2013 /PRNewswire/ -- Health systems professionals should prepare now for the introduction of biosimilars, a new category of pharmaceuticals intended to offer lower cost alternatives for some of the most expensive medications purchased by health care organizations.  This insight comes from newly published research co-authored by Novation, the leading health care supply chain expertise, analytics and contracting company.

The primer, "Biosimilars: Implications for health-system pharmacists," appears in the Nov. 15 issue of the American Journal of Health-System Pharmacy (AJHP).  The peer-reviewed article provides an update on the scientific, regulatory, and clinical practice considerations that are continuing to shape the developing market of biosimilars in the United States. Unlike generic small molecules, biosimilars represent a greater level of complexity in design, manufacturing, and potential for immunogenicity.  As a result, they will require more robust clinical evaluation prior to formulary adoption.  Health care practitioners, particularly pharmacists, must take action now to enable their organizations to realize the full extent of value offered by these products.

According to lead author Steven Lucio, PharmD, BCPS, senior director, Clinical Solutions and Pharmacy Program Development, Novation, "While the development of biosimilars has been slow, we are rapidly approaching a point in time where these products no longer reside in only theoretical terms. Health-system pharmacists must recognize the unique molecular and manufacturing characteristics that differentiate small molecules from biologics and prepare to entertain clinical safety and efficacy discussions of biosimilars. Fortunately, we have the European experience with biosimilars to serve as an example."

Lucio added, "In addition, hospitals' existing familiarity with the sound principles of therapeutic interchange will enable them to support effective formulary management of this new class of pharmaceuticals."

The paper was co-authored by Jim Stevenson, chief pharmacy officer of the University of Michigan Health System and James Hoffman, medication outcomes and safety officer for St. Jude Children's Research Hospital. 

The primer can be downloaded by AJHP subscribers at www.ajhp.org.  For questions about this article, please contact Steven Lucio at slucio@novationco.com.

About Novation, Winner of the Ethics Inside® Certification

Founded in 1998, Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 65,000 members and affiliates of VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, and Provista members used Novation contracts to purchase approximately $43 billion in 2012. Novation earned the coveted Ethics Inside Certification from Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance. Novation was also named on Ethisphere's World's Most Ethical Companies list, and is the only company in the health care industry to earn both distinctions. To learn more about Novation, please visit www.novationco.com and follow @NovationNews.


'/>"/>
SOURCE Novation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
2. L.S.E. (Barcelona) anuncia la primera financiación del antiplaquetario NmC por inversores españoles y suizos
3. El Reino Unido, primer país europeo en ejecutar el programa Zostavax
4. PrimerLife.com, a Skolkovo Participant Company, Celebrates Anniversary of DNA Discovery with Launch of New Social Network
5. PrimerLife.com celebra el aniversario del descubrimiento del ADN con una nueva red social
6. Tras el exitoso lanzamiento en Estados Unidos, el nuevo Simbionix U/S Mentor se introducirá por primera vez en Europa
7. Ziehm Imaging: Primer brazo C motorizado para su uso en ORs híbridos
8. CryoLife anuncia el primer implante europeo del injerto HeRO
9. Aratana Therapeutics to Host Pet Therapeutics Primer and Product Update Event
10. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
11. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):